Engineered NK Cells Target CD73 to Attack Hard-to-Treat Lung Adenocarcinoma
Preclinical research shows that natural killer cells engineered with a CD73-targeting receptor kill relapsed or refractory lung adenocarcinoma cells in ...
Preclinical research shows that natural killer cells engineered with a CD73-targeting receptor kill relapsed or refractory lung adenocarcinoma cells in ...
A new review proposes that mature tumor cells can dedifferentiate into cancer stem cells, acting as a non-genetic engine of ...
A review in Cellular Oncology proposes that tumor blood vessels actively regulate antitumor immunity through angiocrine, metabolic and structural mechanisms.
A new review argues that gut bacterial metabolites such as butyrate and indoles can be engineered as programmable drugs to ...
A laboratory study finds that Th17-derived IL-17 signaling activates AKT in cervical carcinoma cell lines, reducing their sensitivity to cisplatin, ...
Preclinical research shows serine supplementation, rather than restriction, suppresses tumor growth and reinvigorates CD8+ T cells by countering tumor cell ...
A new review examines how cationic lipid-based nanoparticles carry RNA, proteins and peptides into cancer cells, and why clinical translation ...
A new open-access review in Cancer Nanotechnology surveys how nanomaterials could improve colorectal cancer diagnosis, targeted therapy, and personalized theranostics.
A ten-year bibliometric analysis of 320 articles finds artificial intelligence research on triple negative breast cancer peaked at 104 publications ...
In a mouse and cell study, caloric restriction and fasting enhanced radiation's tumor-killing effects through the cGAS-STING pathway while protecting ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine